DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Cidado J, Shen M, Grondine M. et al.
Abstract 3572: AZ5576, a novel potent and selective CDK9 inhibitor, induces rapid cell death and achieves efficacy in multiple preclinical hematological models.
Cancer Res 2016;
76 (14) 3572
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.